Ro Yun Kwan, Lee Sangchul, Jeong Chang Wook, Hong Sung Kyu, Byun Seok Soo, Lee Sang Eun
Department of Urology, Seoul National University College of Medicine, Seoul, Korea.
Korean J Urol. 2012 Dec;53(12):826-9. doi: 10.4111/kju.2012.53.12.826. Epub 2012 Dec 20.
To evaluate the impact of primary Gleason grade in Gleason score (GS) 7 prostate cancer on biochemical recurrence (BCR) after radical prostatectomy in Korean men.
We retrospectively reviewed records of 1,026 patients who underwent radical prostatectomy at Seoul National University Bundang Hospital between November 2003 and June 2009. We excluded patients who had received neoadjuvant therapy and had positive resection margins. Finally, 295 and 113 patients with GS 3+4 and GS 4+3, respectively, were included in this study. All patients were followed for at least 2 years.
Of the 408 GS 7 patients, 295 (72.3%) were 3+4 and 113 (27.7%) were 4+3. Mean serum prostate specific antigen level in primary Gleason 3 was 8.99 ng/ml and primary Gleason 4 was 11.11 ng/ml. Patients with GS 4+3 were more likely to have extracapsular extension (30.1% vs. 17.6%, p<0.010) and lymphatic invasion (16.8% vs. 7.1%, p<0.005). After 2 years follow up BCR was detected in a total of 40 patients. In GS 7 with primary Gleason 3, BCR occurred in 15 (5.08%) patients while 20 (17.70%) showed BCR in GS 7 with primary Gleason 4.
In this study of a large, single center cohort of Korean men with GS 7 prostate cancer a noticeable difference in BCR was seen. Primary Gleason grade 4 have a higher risk of BCR compared to primary Gleason grade 3. This information may be useful when counseling patients on their prognosis and further management options.
评估韩国男性 Gleason 评分(GS)为 7 的前列腺癌中,主要 Gleason 分级对根治性前列腺切除术后生化复发(BCR)的影响。
我们回顾性分析了 2003 年 11 月至 2009 年 6 月期间在首尔国立大学盆唐医院接受根治性前列腺切除术的 1026 例患者的记录。我们排除了接受过新辅助治疗和手术切缘阳性的患者。最终,本研究纳入了分别为 GS 3+4 和 GS 4+3 的 295 例和 113 例患者。所有患者均随访至少 2 年。
在 408 例 GS 为 7 的患者中,295 例(72.3%)为 3+4,113 例(27.7%)为 4+3。主要 Gleason 分级为 3 的患者平均血清前列腺特异性抗原水平为 8.99 ng/ml,主要 Gleason 分级为 4 的患者平均血清前列腺特异性抗原水平为 11.11 ng/ml。GS 4+3 的患者更易发生包膜外侵犯(3 的患者平均血清前列腺特异性抗原水平为 8.99 ng/ml,主要 Gleason 分级为 4 的患者平均血清前列腺特异性抗原水平为 11.11 ng/ml。GS 4+3 的患者更易发生包膜外侵犯(30.1% 对 17.6%,p<0.010)和淋巴侵犯(16.8% 对 7.1%,p<0.005)。随访 2 年后,共 40 例患者检测到 BCR。在主要 Gleason 分级为 3 的 GS 7 患者中,15 例(5.08%)发生 BCR,而在主要 Gleason 分级为 4 的 GS 7 患者中,20 例(17.70%)发生 BCR。
在这项对大量韩国 GS 7 前列腺癌单中心队列的研究中,观察到 BCR 存在显著差异。与主要 Gleason 分级为 3 相比,主要 Gleason 分级为 4 的患者 BCR 风险更高。该信息在为患者提供预后和进一步治疗选择的咨询时可能有用。